Announcements Trials
Browse Landscape

Phase

Phase 2 25Phase 3 5Phase NA 3Phase 2/3 3Phase 1/2 3Phase 1 3Phase 4 1

Status

Completed 14Unknown 13Recruiting 7Active not recruiting 5Not yet recruiting 3Withdrawn 2Enrolling by invitation 2Terminated 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Plasma cell 1Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 217Neoplasms 175Lung Neoplasms 94Prostatic Neoplasms 89Colorectal Neoplasms 89Carcinoma, Non-Small-Cell Lung 48Stomach Neoplasms 45Motor Activity 45Carcinoma, Hepatocellular 45Pancreatic Neoplasms 40Uterine Cervical Neoplasms 39Anxiety Disorders 39Rectal Neoplasms 34Head and Neck Neoplasms 31Colonic Neoplasms 30Pain 26Depression 26Esophageal Neoplasms 24Brain Neoplasms 24Disease 23Polycystic Ovary Syndrome 22Multiple Myeloma 22Hematologic Neoplasms 22Endometrial Neoplasms 22Ovarian Neoplasms 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Urinary Bladder Neoplasms 18Pain, Postoperative 18Leukemia, Myeloid, Acute 17Glioblastoma 17

Interventions

toripalimab 1tislelizumab 1sintilimab 1pembrolizumab 1camrelizumab 1Observation 1Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Not yet recruiting × Esophageal Squamous Cell Carcinoma × Clear all
NCT06971848 2026-03-30

ETCABIO

University Hospital, Angers

Phase NA Not yet recruiting
70 enrolled
GastrointestinalLymphoidOther hematologic neoplasmOther solid neoplasmPlasma cellThoracic

Immunoglobulin Light-chain Amyloidosis, Esophageal Squamous Cell Carcinoma, Mesothelioma, Malignant, Carcinoma, Bronchogenic, Heart Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Follicular, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Cholangiocarcinoma, Neoplasms, Plasma Cell

NCT07067450 2025-07-16

Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma

Sichuan University

Phase NA Not yet recruiting
98 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05420480 2022-06-21

Two-field Versus Three-field Lymph Node Dissection in ESCC After Neoadjuvant Therapy

Shanghai Zhongshan Hospital

Phase NA Not yet recruiting
323 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡